Peregrine Pharmaceuticals Inc. (CDMO)

Last Three Months

05-Feb-24 -- 04-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

22

0

2

+1

0

+2

0

+3

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-May-24 8:20 PM View:	30-Apr-24 Sale ($20.91K)	Hart Daniel Ryan Chief Financial Officer		Peregrine Pharmaceuticals Inc. - CDMO	4% 79.31K to 82.22K	0	0	--	--	Show Txns Hide Txns

02-May-24 8:21 PM View:	30-Apr-24 Sale ($12.16K)	Ziebell Mark R V. P., General Counsel		Peregrine Pharmaceuticals Inc. - CDMO	2% 63.27K to 64.83K	0	0	--	--	Show Txns Hide Txns

02-May-24 8:20 PM View:	30-Apr-24 Sale ($87.03K)	Green Nicholas Stewart President & CEO Director		Peregrine Pharmaceuticals Inc. - CDMO	6% 192.49K to 203.61K	0	0	--	--	Show Txns Hide Txns

02-May-24 8:21 PM View:	30-Apr-24 Sale ($0.81K)	Richieri Richard A. Chief Operations Officer		Peregrine Pharmaceuticals Inc. - CDMO	5% 30.83K to 32.48K	0	0	--	--	Show Txns Hide Txns

02-May-24 8:20 PM View:	30-Apr-24 Sale ($9.12K)	Kwietniak Matthew R. Chief Commercial Officer		Peregrine Pharmaceuticals Inc. - CDMO	10% 19.83K to 21.8K	0	0	--	--	Show Txns Hide Txns